Enveric Biosciences Files 8-K with Financials
Ticker: ENVB · Form: 8-K · Filed: Jan 3, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Jan 3, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, regulatory-disclosure
Related Tickers: ENVB
TL;DR
Enveric Biosciences (ENVB) filed an 8-K on Jan 3, 2025, with financial updates.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on January 3, 2025, reporting information under Regulation FD and including financial statements and exhibits. The company, formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC, is incorporated in Delaware and headquartered in Naples, Florida.
Why It Matters
This filing provides an update on Enveric Biosciences' regulatory disclosures and financial reporting, which is crucial for investors to assess the company's current status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, primarily containing financial statements and exhibits, with no immediate indication of significant new risks.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- AMERI Holdings, Inc. (company) — Former company name
- SPATIALIZER AUDIO LABORATORIES INC (company) — Former company name
- January 3, 2025 (date) — Date of report
- Naples, FL (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Enveric Biosciences, Inc.?
The primary purpose of this 8-K filing is to report information under Regulation FD and to include financial statements and exhibits.
When was this 8-K filed by Enveric Biosciences, Inc.?
This 8-K was filed on January 3, 2025.
What are the former names of Enveric Biosciences, Inc.?
Enveric Biosciences, Inc. was formerly known as AMERI Holdings, Inc. and SPATIALIZER AUDIO LABORATORIES INC.
Where are Enveric Biosciences, Inc.'s principal executive offices located?
Enveric Biosciences, Inc.'s principal executive offices are located at 4851 Tamiami Trail N, Suite 200, Naples, FL 34103.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 596 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-01-03 16:15:23
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 379KB
- ex99-1_002.jpg (GRAPHIC) — 372KB
- ex99-1_003.jpg (GRAPHIC) — 465KB
- ex99-1_004.jpg (GRAPHIC) — 336KB
- ex99-1_005.jpg (GRAPHIC) — 353KB
- ex99-1_006.jpg (GRAPHIC) — 369KB
- ex99-1_007.jpg (GRAPHIC) — 294KB
- ex99-1_008.jpg (GRAPHIC) — 162KB
- ex99-1_009.jpg (GRAPHIC) — 257KB
- ex99-1_010.jpg (GRAPHIC) — 383KB
- ex99-1_011.jpg (GRAPHIC) — 414KB
- ex99-1_012.jpg (GRAPHIC) — 267KB
- ex99-1_013.jpg (GRAPHIC) — 282KB
- ex99-1_014.jpg (GRAPHIC) — 362KB
- ex99-1_015.jpg (GRAPHIC) — 233KB
- 0001493152-25-000247.txt ( ) — 7013KB
- envb-20250103.xsd (EX-101.SCH) — 3KB
- envb-20250103_lab.xml (EX-101.LAB) — 33KB
- envb-20250103_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 3, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer